- Home
- STNE vs IBRX Comparison
STNE vs IBRX Comparison
Compare STNE & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STNE
- IBRX
- Stock Information
- Founded
- STNE 2012
- IBRX 2014
- Country
- STNE Cayman Islands
- IBRX United States
- Employees
- STNE N/A
- IBRX N/A
- Industry
- STNE EDP Services
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STNE Technology
- IBRX Health Care
- Exchange
- STNE Nasdaq
- IBRX Nasdaq
- Market Cap
- STNE 2.9B
- IBRX 2.4B
- IPO Year
- STNE 2018
- IBRX N/A
- Fundamental
- Price
- STNE $12.26
- IBRX $2.47
- Analyst Decision
- STNE Buy
- IBRX Strong Buy
- Analyst Count
- STNE 8
- IBRX 5
- Target Price
- STNE $14.50
- IBRX $11.35
- AVG Volume (30 Days)
- STNE 6.8M
- IBRX 8.0M
- Earning Date
- STNE 05-08-2025
- IBRX 05-08-2025
- Dividend Yield
- STNE N/A
- IBRX N/A
- EPS Growth
- STNE N/A
- IBRX N/A
- EPS
- STNE N/A
- IBRX N/A
- Revenue
- STNE $2,059,718,513.00
- IBRX $14,745,000.00
- Revenue This Year
- STNE $23.38
- IBRX $621.53
- Revenue Next Year
- STNE $7.41
- IBRX $163.57
- P/E Ratio
- STNE N/A
- IBRX N/A
- Revenue Growth
- STNE 12.10
- IBRX 2270.58
- 52 Week Low
- STNE $7.72
- IBRX $2.28
- 52 Week High
- STNE $17.09
- IBRX $10.53
- Technical
- Relative Strength Index (RSI)
- STNE 66.75
- IBRX 41.67
- Support Level
- STNE $10.15
- IBRX $2.35
- Resistance Level
- STNE $12.05
- IBRX $3.04
- Average True Range (ATR)
- STNE 0.66
- IBRX 0.28
- MACD
- STNE 0.09
- IBRX -0.02
- Stochastic Oscillator
- STNE 100.00
- IBRX 13.19
About STNE StoneCo Ltd.
StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs great solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services offers payments, digital banking, and credit solutions, focusing Ton solution mainly on micro-merchants, and Stone solution on SMBs. In Software, it offers POS and ERP solutions for different retail and services verticals, Customer Relationship Management, engagement tools, e-commerce, and Order Management System solutions, among others.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.